Stockholm - Free Realtime Quote SEK
Oncopeptides AB (publ) (ONCO.ST)
As of 1:21 PM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 3 | 3 |
| Avg. Estimate | 0 | 0 | -1.8 | -0.94 |
| Low Estimate | 0 | 0 | -2.34 | -1.2 |
| High Estimate | 0 | 0 | -1.3 | -0.61 |
| Year Ago EPS | -- | -0.93 | -1.97 | -1.8 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 3 | 3 |
| Avg. Estimate | 7M | -- | 84M | 199.33M |
| Low Estimate | 7M | -- | 37M | 123M |
| High Estimate | 7M | -- | 128M | 305M |
| Year Ago Sales | -- | -- | 35.22M | 84M |
| Sales Growth (year/est) | -- | -- | 138.50% | 137.30% |
Earnings History
| CURRENCY IN USD | 3/31/2022 | 6/30/2022 | 9/30/2022 | |
|---|---|---|---|---|
| EPS Est. | -- | -1.53 | -0.62 | -0.51 |
| EPS Actual | -- | -0.93 | -0.56 | -0.71 |
| Difference | -- | 0.6 | 0.06 | -0.2 |
| Surprise % | -- | 39.20% | 9.70% | -39.20% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -1.8 | -0.94 |
| 7 Days Ago | 0 | 0 | -1.8 | -0.94 |
| 30 Days Ago | 0 | 0 | -1.8 | -0.94 |
| 60 Days Ago | 0 | 0 | -1.29 | -0.91 |
| 90 Days Ago | 0 | 0 | -1.28 | -0.76 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ONCO.ST | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 3.60% |
| Next Qtr. | -- | -- | -- | 7.90% |
| Current Year | 8.60% | -- | -- | 2.50% |
| Next Year | 47.80% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.87% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Related Tickers
ATORX.ST Alligator Bioscience AB (publ)
1.2060
-4.44%
ACE.ST Ascelia Pharma AB (publ)
2.2000
-0.23%
KAN.ST Kancera AB (publ)
1.8800
-0.42%
XBRANE.ST Xbrane Biopharma AB (publ)
0.2125
+18.06%
QUIA.ST Quia Pharma AB (publ)
0.0190
-5.00%
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.1820
-1.09%
CYXO.ST Cyxone AB (publ)
0.0410
+2.50%
ABLI.ST Abliva AB (publ)
0.1578
+1.81%
ULTI.OL Ultimovacs ASA
1.9300
+6.04%
EGTX.ST Egetis Therapeutics AB (publ)
4.7050
0.00%